- Home
- XRAY vs DNLI Comparison
XRAY vs DNLI Comparison
Compare XRAY & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRAY
- DNLI
- Stock Information
- Founded
- XRAY 1899
- DNLI 2013
- Country
- XRAY United States
- DNLI United States
- Employees
- XRAY N/A
- DNLI N/A
- Industry
- XRAY Medical/Dental Instruments
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XRAY Health Care
- DNLI Health Care
- Exchange
- XRAY Nasdaq
- DNLI Nasdaq
- Market Cap
- XRAY 3.8B
- DNLI 3.1B
- IPO Year
- XRAY 1987
- DNLI 2017
- Fundamental
- Price
- XRAY $18.74
- DNLI $20.82
- Analyst Decision
- XRAY Buy
- DNLI Strong Buy
- Analyst Count
- XRAY 13
- DNLI 13
- Target Price
- XRAY $24.50
- DNLI $37.91
- AVG Volume (30 Days)
- XRAY 2.2M
- DNLI 824.2K
- Earning Date
- XRAY 02-27-2025
- DNLI 03-04-2025
- Dividend Yield
- XRAY 3.34%
- DNLI N/A
- EPS Growth
- XRAY N/A
- DNLI N/A
- EPS
- XRAY N/A
- DNLI N/A
- Revenue
- XRAY $3,900,000,000.00
- DNLI N/A
- Revenue This Year
- XRAY N/A
- DNLI N/A
- Revenue Next Year
- XRAY N/A
- DNLI $289.18
- P/E Ratio
- XRAY N/A
- DNLI N/A
- Revenue Growth
- XRAY N/A
- DNLI 204.74
- 52 Week Low
- XRAY $17.21
- DNLI $14.56
- 52 Week High
- XRAY $34.91
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- XRAY 50.39
- DNLI 49.90
- Support Level
- XRAY $18.02
- DNLI $21.33
- Resistance Level
- XRAY $19.18
- DNLI $22.81
- Average True Range (ATR)
- XRAY 0.47
- DNLI 1.20
- MACD
- XRAY 0.00
- DNLI -0.02
- Stochastic Oscillator
- XRAY 56.00
- DNLI 45.17
About XRAY DENTSPLY SIRONA Inc.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.